Purpose
To investigate the risk of keratoconus (KCN) in patients with atopic keratoconjunctivitis (AKC).
Methods
This nationwide, retrospective, matched cohort study included 186 202 newly diagnosed AKC patients who were identified by the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM), code 372.05, and selected from the Taiwan National Health Insurance Research Database. The age‐ and sex‐matched control group included 186 202 non‐AKC patients selected from the Taiwan Longitudinal Health Insurance Database 2000. Patient information was collected between 1 January 2004 and 31 December 2011, and both groups of patients were tracked from the index date until December 2013. The incidence and risk of KCN (ICD‐9‐CM, code 371.6) were compared between the groups. A Cox proportional hazard regression analysis was performed to obtain the adjusted hazard ratio (HR) for KCN. The cumulative KCN incidence rate was calculated with the Kaplan‐Meier analysis.
Results
In total, 62 AKC patients and 26 controls developed KCN during the follow‐up period. The incidence rate of KCN was 2.49 times (95% confidence interval [CI] = 1.57–3.93; p < 0.0001) higher in AKC patients than in controls. After adjusting for potential confounders, AKC patients were 2.25 times more likely to develop KCN than controls (adjusted HR, 2.25; 95% CI = 1.41–3.58; p < 0.05).
Conclusion
Atopic keratoconjunctivitis (AKC) patients had an increased risk of developing KCN. Therefore, AKC patients should be advised of this risk.